Medical Isotopes Market on Path to Hit $9.5 Billion by 2029 at 7% CAGR

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

Medical Isotopes Market Outlook: What Size And CAGR Are Anticipated By 2025?
The market size for medical isotopes has seen robust growth in the past few years. It's projected to expand from $6.8 billion in 2024 to $7.26 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this growth during the historical period include an increase in chronic diseases, pharmaceutical industry expansion, progress in cancer treatments, the need for diagnostic imaging, and developments in nuclear medicine.

What Is the Expected CAGR for the Medical Isotopes Market Growth Through 2029?
Expectations are high for robust expansion in the medical isotopes market size over the coming years. It is projected to attain a market value of $9.5 billion in 2029, with a 7.0% compound annual growth rate (CAGR). The anticipated growth during this forecast period is credited to various factors such as public health measures, partnerships and collaborations, improvements in infrastructure, a tendency towards personalized medicine, an increasing elderly population, modifications in regulations, and standards. Key trends predicted for this period encompass growth in radiopharmaceuticals, implementation of cyclotron and generator technologies, emphasis on resilient supply chains, artificial intelligence (AI) integration, and advances in positron emission tomography (PET) imaging.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/medical-isotopes-global-market-report

What Are the Primary Drivers Behind Medical Isotopes Market Growth?
The medical isotope market is projected to expand due to increasing rates of cancer and heart disease. The number of new cases and prevalence of these diseases over a given time provides vital information about public health and the effectiveness of preventive measures. Modern technology and sedentary professions encourage a lifestyle that increases the risk of cancer and heart disease due to decreased physical activity. Medical isotopes play a crucial role in diagnosing and treating these diseases with imaging techniques like positron emission tomography (PET) and single photon emission computed tomography (SPECT) scans, as well as radiation therapy and radioactive stents. For instance, the World Health Organization, a Switzerland-based intergovernmental organization, predicted in February 2024 that there would be over 35 million new cancer cases by 2050, a 77% increase from the estimated 20 million cases in 2022. Additionally, data published by the British Heart Foundation, a UK-based cardiovascular research charity, in September 2024 revealed that roughly 7.6 million people in the UK suffer from heart and circulatory diseases, comprising around 4 million males and 3.6 million females. About 27% of all deaths in the UK are due to these diseases, resulting in over 170,000 annual deaths or nearly 480 deaths each day. In other words, there is one death every three minutes. Consequently, the medical isotope market is experiencing growth due to the increasing rates of cancer and heart disease.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15853&type=smp

What Are the Key Segments Driving Medical Isotopes Market Growth?
The medical isotopes market covered in this report is segmented -

1) By Product Type: Stable Isotopes, Radio Isotopes
2) By Production Method: Neutron Activation, Cyclotron, Nuclear Reactor, Other Production Method
3) By Application: Nuclear Therapy, Equipment Radioactive Source, Diagnosis
4) By End Use: Hospitals, Diagnostic Centers, Research Institutes

Subsegments:
1) By Stable Isotopes: Carbon-13, Nitrogen-15, Oxygen-18, Other Stable Isotopes
2) By Radio Isotopes: Technetium-99m, Iodine-131, Cobalt-60, Strontium-89, Other Radio Isotopes

What Are the Technological Trends Impacting the Medical Isotopes Market?
Prominent businesses engaged in the medical isotope industry are leveraging strategic alliances as a tool to gain a market advantage. A strategic alliance refers to a formal pact made amongst two or more entities, working cooperatively to achieve certain agreed-upon targets that offer mutual advantages. For example, in September 2023, International Isotopes Inc., a corporation based in the United States that specializes in medical technology, formed a partnership with Phantech Medical, another US-based enterprise working on biomedical hardware. Their intention behind this collaboration is to bring about a transformative shift in the calibration and reference sources sector for pre-clinical imaging. Specifically, they plan to design, produce, and distribute novel sealed sources for use in medical imagery and theranostics circles.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15853&type=smp

Who Are the Major Competitors in the Global Medical Isotopes Market?
Major companies operating in the medical isotopes market are Rosatom State Atomic Energy Corporation, Bayer AG, Siemens Healthineers AG, GE HealthCare, Urenco Ltd., Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien München AG (ITM), Eczacıbaşı-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions, Izotóp, Coquí RadioPharmaceuticals Corp., Jubilant DraxImage Inc., Positron Corporation

Which Region Dominates the Medical Isotopes Market Share in 2025?
North America was the largest region in the medical isotopes market in 2024. The regions covered in the medical isotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.